Malignancy Risk Varies with Treatment in Systemic Necrotizing Vasculitis
FDA Approves Rituximab for Children with GPA & MPA
Stay the Course: How to Maintain Remission in Vasculitis
Large Vessel Vasculitis Outcome Measures: An Update from OMERACT
Advocate for Prompt Vasculitis Diagnosis & Treatment
Experts Discuss Proposed Giant Cell Arteritis Risk Tool
Kussmaul, Meier & Polyarteritis Nodosa
Intriguing Patient Cases Presented at the ACR Annual Meeting Thieves Market
New Rheumatology Disease Research & Advice
- 1
- 2
- 3
- …
- 6
- Next Page »